Reclassification of promoters to public
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Ltd has received shareholder approval (via postal ballot from November 12 to December 11, 2025) to reclassify four members of the promoter/promoter group as 'Public' shareholders. The outgoing promoters — Mr. Sai Sudhakar Vankineni (0.08%), Ms. Snigdha Vankineni (1.47%), Mr. Sumanth Simha Vankineni (0.93%), and Mrs. Jhansi Rani Vankineni (0.07%) — together hold 9,42,700 equity shares (2.55% of paid-up capital). BSE had already granted its no-objection on October 16, 2025. The outgoing promoters have confirmed they will not hold more than 10%, will not exercise control, will have no board representation, and are not wilful defaulters or fugitive economic offenders.
The promoter group's effective shareholding will reduce by 2.55% as these shareholders move to the public category, which may slightly increase the public float. This is a structural reclassification rather than a sale, so there is no immediate impact on share price, but it signals a reduction in promoter influence in the company.